RDIF announced plans to produce Sputnik V in Italy

World News

RDIF announced plans to produce Sputnik V in Italy

Kirill Dmitriev, head of the Russian Direct Investment Fund (RDIF), spoke about cooperation with the Swiss company Adienne Pharma & Biotech for the production of the Sputnik V coronavirus vaccine in Italy. He announced this in an interview with the Rai 3 TV channel, TASS reports.

According to Dmitriev, new jobs will appear thanks to the production mechanism. It is expected that the production of the Russian drug in Italy could begin in the summer, and by the end of 2021 the number of vaccines produced could reach 700 million doses.

Sputnik V became the world's first registered vaccine based on the human adenovirus. Currently, the development of Russian scientists is among the ten best vaccine candidates in the list of the World Health Organization (WHO). The vaccine has already been registered in Russia, Belarus, Argentina, Mexico, Bolivia, Serbia, Algeria, Armenia, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, UAE, Iran, Republic of Guinea and Tunisia.

The Pentagon plans to create a rehabilitation center in Ukraine

The US Navy's Civil Engineering Command in Europe, Africa and Southwest Asia has indicated its interest in rebuilding an old Read more

More than 175 million years old bacteria discovered in Death Valley

More than 175 million years old bacteria discovered in Death Valley American scientists from the Bigelow Ocean Science Laboratory have Read more

Leave a Reply